Assessment of the association of baseline anti-CarbV and anti-MCV antibodies with response to treatment and radiographic progression in an RA population treated with either methotrexate or baricitinib: post-hoc analyses from RA-BEGIN

Assessment of the association of baseline anti-CarbV and anti-MCV antibodies with response to treatment and radiographic progression in an RA population treated with either methotrexate or baricitinib: post-hoc analyses from RA-BEGIN

Abstract Background The development of autoantibodies in patients with rheumatoid arthritis (RA) has potential as a marker of treatment response. This analysis assessed the association of an autoantibody response to carbamylated vimentin (anti-CarbV) and to vimentin modified by citrullination (anti-...

Full description

Bibliographic Details
Main Authors: Pedro López-Romero, Lorena Martinez-Gamboa, Holger Bang, Inmaculada de la Torre, Thorsten Holzkämper, Eugen Feist
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Baricitinib
Autoantibodies
Anti-CarbV
Online Access:http://link.springer.com/article/10.1186/s13075-020-02284-y

Internet

http://link.springer.com/article/10.1186/s13075-020-02284-y

Similar Items